SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indoco Remedies informs about change in management

28 Jul 2026 Evaluate
Indoco Remedies has informed that the Board of Directors in its Meeting held today i.e. 28th July, 2026 has considered and approved Re-appointment of Aditi Panandikar as the Managing Director of the Company for the period of 5 years commencing from 15th February, 2027 to 14th February, 2032, subject to the approval of the shareholders in the ensuing AGM; and appointment of Sudhir Kadam as Senior Management Personnel designated as Sr. Vice President (Human Capital) of the Company with effect from 28th July, 2026.

The above information is a part of company’s filings submitted to BSE.

Indoco Remedies Share Price

225.80 -2.30 (-1.01%)
29-Jul-2026 15:13 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1990.00
Dr. Reddys Labs. 1142.00
Cipla 1473.70
Lupin 2445.40
Zydus Lifesciences 1123.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: